The joint pain injections market consists of therapies which offer local anesthetics and corticosteroids. These therapies help provide relief from pain caused due to arthritis and musculoskeletal injuries. Joint pain injections help reduce inflammation and pain at the site of injection. Some of the common types of joint injections include corticosteroid injections which help reduce joint swelling, hyaluronic acid injections that help lubricate joints, platelet-rich plasma injections which use concentrated platelets from a patient's own blood to help stimulate healing. The rising prevalence of osteoarthritis and muscle injuries is fueling the demand for joint pain injections.
The global joint pain injections market is estimated to be valued at USD 5.76 Bn in 2025 and is expected to reach USD 10.47 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032.
Key Takeaways
Key players operating in the joint pain injections market are copyright, Inc., Ferring Pharmaceuticals Inc., PACIRA BIOSCIENCES, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Sanofi, Anika Therapeutics, Inc., Bioventus, Dr. Reddy’s Laboratories Ltd., Zimmer Biomet, Ferring B.V., SEIKAGAKU CORPORATION, and Ono Pharmaceutical Co., Ltd.
Joint Pain Injections Market Demand is driven by the growing geriatric population, projected to exceed 1.5 billion by 2050. The elderly are more susceptible to joint disorders like osteoarthritis, fueling demand for pain therapies.
Technological advancements are helping physicians administer injections with greater precision. Advanced injection devices with computerized controls and feedback mechanisms are now available which help ensure correct administration. 3D printing is also being explored to custom-make joint implants.
Market Trends
Increasing adoption of regenerative medicine therapies - Therapies using PRP and stem cells are gaining popularity as they help stimulate natural healing of joints.
Rise in home healthcare - With the pandemic, more patients are opting for home-based injection therapies for safety and convenience. This is accelerating the shift towards single-use injection devices with easy self-administration features.
Market Opportunities
Growing demand in emerging nations - Countries like China, India, Brazil, and Mexico have a huge aging population but limited availability of joint therapies currently. These represent key expansion opportunities.
Exploring biologics - Biologic drugs mimicking natural joint lubricants are being researched which may emerge as an important new class of treatments.
Impact of COVID-19 on Joint Pain Injections Market
The COVID-19 pandemic has had a significant impact on the growth of the joint pain injections market. During the initial lockdown phases in 2020, elective procedures like joint injections were postponed or canceled to avoid hospital visits and focus resources on critical care. This led to a steep decline in procedure volumes and negatively impacted the market revenues. However, as lockdowns eased, the demand started recovering from mid-2020 as backlogged cases were addressed and new patients sought treatment. Telehealth also emerged as an important medium to triage and consult patients to limit physical visits. Virtual platforms helped specialists determine the urgency of procedures and prioritize cases. This supported the market to a certain degree during the peak pandemic periods. Looking forward, as vaccination drives progress globally, procedural volumes are expected to normalize. However, supply chain disruptions caused by the pandemic may continue affecting market players in the short-term. Overall, COVID-19 delayed the market growth trajectory in the short-run but long-term prospects remain optimistic as joint pain continues to rise.
Geographical Regions of Concentration
North America currently dominates the global joint injections market and accounts for over 40% of the total market value. This is attributed to the high prevalence of arthritis and other musculoskeletal disorders in the region. According to CDC, over 30 million adults in the US suffer from arthritis. Moreover, the region has advanced healthcare infrastructure and higher accessibility to novel therapies compared to other regions. Within North America, the US represents the single largest market and is expected to continue leading over the forecast period given its large elderly population base and higher healthcare spending.
Asia Pacific Joint Injections Market
Asia Pacific is emerging as the fastest growing regional market for joint injections propelled by China and India. Rapid economic development, rising income levels, growing medical tourism and increased awareness about joint pain management options are fueling the demand in the region. The number of key opinion leaders and innovative market players is also increasing in the APAC region. Moreover, the rising geriatric population afflicted by arthritis and other joint disorders presents lucrative opportunities for market participants to strengthen their presence. With expected economic prosperity and continued healthcare reforms, the APAC region will witness highest growth rates in the global joint injections market over the next decade.
Get More Insights - Joint Pain Injections Market
Get This Report in Japanese Language -関節痛注射市場
Get This Report in Korean Language - 관절 통증 주사 시장
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
copyright src="chrome-extension://fpjppnhnpnknbenelmbnidjbolhandnf/content_script_web_accessible/ecp_regular.js" type="text/javascript">